NewRoute Pharmaceutical Technology Co., Ltd. (established in 2012) is a high-tech enterprise specializing in the R&D, production and sale of pharmaceutical APIs, intermediates, fine chemicals, formulations, and impurity reference standards. The company’s R&D and office facilities cover a total area of 9,000 m², including approximately 2,000 m² dedicated to formulation R&D, 2,000 m² for testing and analysis services, 3,000 m² for API development, and 2,000 m² for administrative offices. Its equipment assets are valued at nearly 100 million yuan.
Our products serve major therapeutic areas including anti-infectives, antivirals, cardiovascular and GI treatments. As a domestic leader in antibiotic APIs, we specialize in β-lactams, β-lactamase inhibitors, carbapenems and tetracyclines, with end-to-end R&D and manufacturing capabilities.
Our production site, located in Henan Province, covers an area of approximately 25,000 m² and specializes in the R&D and production of pharmaceutical intermediates, with a core focus on chiral chemical synthesis and innovative drug intermediate development. Equipped with dedicated production lines and pilot-scale facilities, it provides customized intermediates from kilogram to ton scale.
